Adverse reactions caused by antimicrobials in hospitalized pediatric patients
causality and avoidability analysis
DOI:
https://doi.org/10.1590/s2175-97902022000X20799Keywords:
Adverse Drug Reactions, Pediatrics, Antimicrobials, Causality, AvoidabilityAbstract
In pediatrics, drug therapy is commonly performed through adaptations of the dosage forms to adult use, increasing the risk of adverse drug reactions. In this context, studies assessing the severity and avoidability of the adverse reactions in children, especially those caused by antimicrobials, are still scarce. This work aimed to investigate suspected antimicrobial adverse reactions (ATM-ADRs) in pediatric patients admitted to a public hospital in northeastern Brazil, focusing on causality and avoidability analysis. A cohort study was carried out over a period of six months in a 64-bed pediatric unit. The incidence of suspected adverse reactions caused by antimicrobials was 14.65%. Most reactions were rated as probable (89.13%), with moderate severity (84.78%) and possibly avoidable (45.65%). The analysis indicated that the use of a larger number of medications (p<0.0001) and longer hospital stay (p=0.004) were related to the occurrence of ATM-ADR. Our findings demonstrated that almost half of the suspected reactions could be prevented and that the antimicrobial’s clinical management is relevant in this context. Besides, increasingly accurate adverse reaction classification instruments are essential. These results can support the development of therapeutic guidelines addressed to a safe and effective pharmacotherapy in the pediatric area.
Downloads
References
Andrade PHS, Santos ADS, Souza CAS, Lobo IMF, da Silva WB. Risk factors for adverse drug reactions in pediatric inpatients: a systematic review. Ther Adv Drug Saf. 2017;8(6):199-210.
Bauters T, Claus B, Schelstraete P, Robays H, Benoit Y, Dhooge C. Vancomycin-induced red man syndrome in pediatric oncology: still an issue? Int J Clin Pharm. 2012;34(1):13-6.
Becker ML, Leeder JS. Identifying genomic and developmental causes of adverse drug reactions in children. Pharmacogenomics. 2010;11(11):1591-1602.
Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm . 2018;40(4):903-910.
Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, et al. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool. PLoS One. 2017;12(1):e0169393.
Cliff-Eribo KO, Sammons H, Choonara I. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Expert Opin Drug Saf. 2016;15(10):1321-8.
de Las Salas R, Díaz-Agudelo D, Burgos-Flórez FJ, Vaca C, Serrano-Meriño DV. Adverse drug reactions in hospitalized Colombian children. Colomb Med (Cali). 2016;47(3):142-147.
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9.
Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics. 2011;3(1):53-72.
Fonteles MMF, Francelino EV, Santos LKX, Silva KM, Siqueira R, Viana GSB, et al. Reações adversas causadas por fármacos que atuam no sistema nervoso: análise de registros de um centro de farmacovigilância do Brasil. Rev. psiquiatr. clín. [Internet]. 2009;36(4):137-144. Available from: Http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-60832009000400003&lng=en
» Http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-60832009000400003&lng=en
Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf . 2018;17(7):681-695.
Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One . 2011;6(12):e28096.
Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, Williamsonet PR, et al. Adverse drug reactions causing admission to a paediatric hospital. PLoS One . 2012;7(12):e50127.
Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic- associated diarrhea. Cochrane Database Syst Rev. 2019;30(4):CD004827.
Guragain S, Upadhayay N, Bhattarai BM. Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study. Clin Pharmacol. 2017;9:73-78.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229-32.
Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016;24(4):485-493.
Lima EDC, Matos GC, Vieira JML, Gonçalves ICDCR, Cabral LM, Turner MA. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study. J Pediatr (Rio J). 2019;95(6):682-688
Milutinović, D, Simin D, Zec D. Fatores de risco para flebite: estudo com questionário sobre a percepção dos enfermeiros. Rev Latino-Am Enfermagem. 2015;23(4):677-684.
Mouton JP, Mehta U, Rossiter DP, Maartens G, Cohen K. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system. PLoS One . 2017;12(2):e0172830.
Mungan Z, Pınarbaşı Şimşek B. Which drugs are risk factors for the development of gastroesophageal reflux disease? Turk J Gastroenterol. 2017;28(Suppl1):S38-S43.
Principi N, Esposito S. Antimicrobial stewardship in paediatrics. BMC Infect Dis. 2016;16(1):424.
Qing-ping S, Xiao-dong J, Feng D, Yan L, Mei-ling Y, Jin- xiu Z, et al. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv Res. 2014;14:73.
Raut A, Kalrao VR, Rani R, Kumar R. A Prospective Study of Adverse Drug Reactions in 1 Month-12 Years Old Pediatric Patients. Indones J Clin Pharm. 2015;4(1):17-27.
Sandhu DS, Fass R. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut Liver. 2018;12(1):7-16.
Santos L, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Farm Hosp. 2012;36(4):180-186.
Shalviri G, Yousefian S, Gholami K. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre. J Clin Pharm Ther. 2012;37(4):448-51.
Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children-a systematic review. PLoS One . 2012;7(3):e24061.
Souza MOB, Araújo MCC, Santiago RA, Coelho HLL, Fonteles MMF. Adverse reactions to oxacillin in hospitalized children: a prospective study. Rev Bras Saude Mater Infant. [Internet]. 2007;7(1):55-61. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292007000100007&lng=en http://dx.doi.org/10.1590/S1519-38292007000100007.
» https://doi.org/http://dx.doi.org/10.1590/S1519-38292007000100007
» http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292007000100007&lng=en
Tuleu C, Breitkreutz J. Educational paper: formulation- related issues in pediatric clinical pharmacology. Eur J Pediatr. 2013;172(6):717-20.
Vázquez-Alvarez AO, Brennan-Bourdon LM, Rincón-Sánchez AR, Islas-Carbajal MC, Huerta-Olvera SG. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients. BMC Pharmacol Toxicol. 2017;18(1):79.
WHO (World Health Organization). Adverse Reaction Terminology. Uppsala: The Uppsala Monitoring Centre, 1997.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
